Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-19-000143
Filing Date
2019-03-22
Accepted
2019-03-22 17:02:54
Documents
1
Group Members
ARCH VENTURE PARTNERS VII, L.P.ARCH VENTURE PARTNERS VII, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VII, L.P. - SCHEDULE 13D/A - AMENDMENT NO. 4 pulmatrix13da_18302.htm SC 13D/A 193957
  Complete submission text file 0001072613-19-000143.txt   195811
Mailing Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631
Business Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631 773-380-6600
ARCH Venture Fund VII, L.P. (Filed by) CIK: 0001402439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Subject) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88056 | Film No.: 19700534
SIC: 2834 Pharmaceutical Preparations